North Carolina universities sign deal with Elsevier

Agreement provides access to key scientific and medical information.

Amsterdam, 24 June 2004 - Eleven universities from the North Carolina’s University Library Advisory Council (ULAC), a consortium of sixteen universities throughout the state, have signed a multiple-year agreement with Elsevier for the provision of key scientific and medical texts. Ten universities have signed a five-year agreement and one has signed a three-year agreement.

The agreement gives the ULAC community -- composed of university undergraduates, graduate students, researchers, faculty and staff –complete access to full-text articles from over 1,100 journals, dating back to 1995, and covering some of the most authoritative titles among scientific and medical literature including high impact factor journals such as The Lancet and Tetrahedron.

"(I’m) pleased with Elsevier's efforts to make such a large number of important electronic journals available to East Carolina University with our medical school and a large number of research programs," said Carroll Varner, Ph.D., Director, Academic Library Services, East Carolina University.

The ScienceDirect ULAC Consortium is composed of Appalachian State University, East Carolina University, Elizabeth City State University, Fayetteville State University, North Carolina Agricultural & Technical State University, North Carolina Central University, University of North Carolina Asheville, University of North Carolina - Greensboro, University of North Carolina – Charlotte, University of North Carolina – Wilmington and Winston-Salem State University.

North Carolina residents also benefit under the agreement. Anyone who goes to any of the libraries looking for scientific and medical information will be given free access, as covered under Elsevier’s standard, “walk-up” provision.

“Our negotiations with ULAC were efficient and professional, and we are pleased to be providing valuable content to researchers in the state of North Carolina,” said Frank Vrancken Peeters, Elsevier’s Managing Director for Sales, Science & Technology, Elsevier.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).